GLYCOSYN HEALTH INITIATIVES INC C/O NEWBURG & COMPANY LLP (EIN 263983845) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

STEVEN COHEN

Phone

7818844100

Tax Period

2018-01-01 to 2018-12-31

GLYCOSYN HEALTH INITIATIVES INC C/O NEWBURG & COMPANY LLP, founded in 2009, is a micro nonprofit that reported $3K in total revenue in fiscal year 2018. Revenue surged 486% from the prior year, signaling strong growth momentum. Expenses of $148K exceeded revenue, resulting in a 5126% operating deficit.

Mission

GYLCOSYN HEALTH INITIATIVES, INC IS A BIOTECHNOLOGY THERAPEUTICS AND DIAGNOSTICS ORGANIZATION, DEDICATED TO IMPLEMENTING NEW TREATMENTS AND TECHNOLOGIES TO REDUCE THE IMPACT OF INFANT AND CHILDHOOD DISEASES WORLDWIDE, THE PRIMARY CAUSE OF MORBIDITY AND MORTALITY AMONG CHILDREN IN THIRD WORLD COUNTRIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $2,000

Program Service Revenue $0

Investment Income $826

Other Revenue $0

TOTAL REVENUE $2,826

Expense Breakdown

Grants Paid $17,000

Salaries & Benefits $126,000

Fundraising Expenses $63,021

Program Expenses $80,021

Other Expenses $4,682

TOTAL EXPENSES $147,682

Year-over-Year Comparison

	2018	2017	Change
Revenue	$2,826	$482	+4.9%
Expenses	$147,682	$111,460	+0.3%
Net Income	$-144,856	$-110,978	+0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$126,000

Total Directors

$126,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
STEVEN COHEN	PRESIDENT & DIRECTOR	3.00	Officer Director	$0	$0	$0
JOHN R GARRET PHD	TREASURER & DIRECTOR	30.00	Officer Director	$126,000	$0	$126,000
HOWARD M NEWBURG	CLERK & DIRECTOR	3.00	Officer Director	$0	$0	$0
DAVID S NEWBURG	DIRECTOR	3.00	Director	$0	$0	$0
VIDAR J JORGENSEN	DIRECTOR	3.00	Director	$0	$0	$0
GARY COHEN	DIRECTOR	3.00	Director	$0	$0	$0
PHILLIPS L KUHL	DIRECTOR	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$2,826	$147,682	$68,658	$-144,856

GLYCOSYN HEALTH INITIATIVES INC C/O NEWBURG & COMPANY LLP